You are here: vision-research.eu » News » Newsdetails:

Ocuphire Pharma completes enrollment in MIRA-3 Pivotal Phase 3 clinical trial for Nyxol in RM

The company completed enrollment ahead of schedule in a second Phase 3 FDA registration trial for Nyxol in RM with top-line results expected by the end of the first quarter.